Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Just because it's negative, doesn't mean it's not an important discussion.

Agree! It's just that constant management bashing is not very useful.
In any case, all the "other decisions" that could have been
made, that would have resulted in much higher pps by now,
those are impossible to evaluate, so a systematic rebuttal
is impossible.

All I'm saying is that Pluristem is like most other small biotechs,
it's a real challenge to guide it to the finish line, and I see
"backseat driving" as basically cheapshots at management.

But I certainly don't want to discourage anyone from expressing their
feelings here (but I do reserve the right to respond with a bit
of sarcasm every now and then).

All in all, let's face it, this company is potentially an absolutely
fabulous investment. If the technology works, it could be an
astounding success story, both commercially and in helping
patients.